Safety and activity of CLN-081 (TAS6417) in NSCLC with EGFR Exon 20 insertion mutations (Ins20).
Year: 2021
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Zofia Piotrowska, Helena Alexandra Yu, James Chih-Hsin Yang, Marianna Koczywas, Egbert F. Smit, Daniel Shao-Weng Tan, Victor Ho-Fun Lee, Ross A. Soo, John M. Wrangle, Alexander I. Spira, Vamsidhar Velcheti, Mark A. Socinski, Asher Page, David Witter, Leigh Zawel, Jon M. Wigginton, Myles Steven Clancy, Danny Nguyen
Institutions: Massachusetts General Hospital, Memorial Sloan Kettering Cancer Center, National Taiwan University Hospital, City Of Hope National Medical Center, The Netherlands Cancer Institute, National Cancer Centre Singapore, Queen Mary Hospital, University of Hong Kong, National University Hospital, Medical University of South Carolina, Virginia Cancer Specialists, NYU Langone Health, NYU Langone’s Laura and Isaac Perlmutter Cancer Center, AdventHealth Orlando
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3168080577